$SCLX
Scilex Holding Co Stock $sclx

$sclx Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022069366 Filed on November 04, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$11.92M	$0.00	$0.00
YoY Change
Cost Of Revenue	$4.513M	$6.284M
YoY Change	315.94%
Gross Profit	$7.406M	$19.83M
YoY Change	3.18%
Gross Profit Margin	62.14%
Selling, General & Admin	$23.52M	$41.37M
YoY Change	62.35%
% of Gross Profit	317.63%	208.62%
Research & Development	$2.597M	$6.457M
YoY Change	19.68%
% of Gross Profit	35.07%	32.56%
Depreciation & Amortization	$1.035M	$2.926M
YoY Change	-72.61%
% of Gross Profit	13.98%	14.75%
Operating Expenses	$27.15M	$657.8K	$283.4K
YoY Change	6953.73%	132.13%	4735.32%
Operating Profit	-$19.74M	-$657.7K	-$283.3K
YoY Change	-390.6%	132.14%
Interest Expense	$1.897M	$1.155K	$1.790K
YoY Change	210677.78%	-35.47%
% of Operating Profit
Other Income/Expense, Net		$68.40K	-$1.163M
YoY Change		-105.88%
Pretax Income	-$17.84M	-$131.4K	-$1.444M
YoY Change	-1675.36%	-90.9%	24547.61%
Income Tax	$40.00K	-$36.00K
% Of Pretax Income
Net Earnings	-$17.88M	-$131.4K	-$1.444M
YoY Change	-1678.9%	-90.9%	24547.61%
Net Earnings / Revenue	-150.05%
Basic Earnings Per Share		-$0.01	-$0.08
Diluted Earnings Per Share	-$0.13	-$0.01	-$83.73K
COMMON SHARES
Basic Shares Outstanding	13.18M shares	13.18M shares	17.25M shares
Diluted Shares Outstanding		13.18M shares	17.25M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.184M	$34.96K	$115.6K
YoY Change	329.99%	-69.77%	44.55%
Cash & Equivalents	$2.184M	$34.96K	$115.6K
Short-Term Investments
Other Short-Term Assets	$4.810M	$130.8K	$116.5K
YoY Change	105847.14%	12.23%
Inventory	$1.378M	$933.0K
Prepaid Expenses		$130.8K
Receivables	$21.24M	$17.47M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$29.61M	$165.7K	$232.2K
YoY Change	5677.66%	-28.61%	190.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$772.0K	$2.053M
YoY Change	-4.1%
Goodwill	$13.50M
YoY Change	0.0%
Intangibles	$40.59M
YoY Change	4.61%
Long-Term Investments
YoY Change
Other Assets	$944.0K	$101.3M	$139.4M
YoY Change	-99.32%	-27.34%	126634.55%
Total Long-Term Assets	$56.92M	$101.3M	$139.4M
YoY Change	-59.17%	-27.34%	126634.55%
TOTAL ASSETS
Total Short-Term Assets	$29.61M	$165.7K	$232.2K
Total Long-Term Assets	$56.92M	$101.3M	$139.4M
Total Assets	$86.53M	$101.5M	$139.6M
YoY Change	-38.16%	-27.34%	73394.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.450M	$809.3K	$43.57K
YoY Change	3948.87%	1757.45%
Accrued Expenses	$36.13M	$26.01M	$0.00
YoY Change			-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$44.84M	$809.3K	$43.57K
YoY Change	21385.93%	1757.45%	-74.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$163.0K		$10.05M
YoY Change	2265.06%
Total Long-Term Liabilities	$163.0K	$0.00	$10.05M
YoY Change	2265.06%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.84M	$809.3K	$43.57K
Total Long-Term Liabilities	$163.0K	$0.00	$10.05M
Total Liabilities	$50.29M	$12.17M	$10.09M
YoY Change	444.23%	20.6%	5835.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$375.9M	-$12.00M
YoY Change	4221.96%
Common Stock	$14.00K	$345.00
YoY Change	3957.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00
YoY Change
Treasury Stock Shares
Shareholders Equity	$36.24M	-$12.00M	$129.6M
YoY Change
Total Liabilities & Shareholders Equity	$86.53M	$101.5M	$139.6M
YoY Change	-38.16%	-27.34%	73394.83%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$17.88M	-$131.4K	-$1.444M
YoY Change	-1678.9%	-90.9%	24547.61%
Depreciation, Depletion And Amortization	$1.035M	$2.926M
YoY Change	-72.61%
Cash From Operating Activities	-$725.0K	-$316.3K	-$142.0K
YoY Change	573.04%	122.78%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$2.067M
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$40.85M	$0.00
YoY Change
Cash From Investing Activities	$0.00	$40.85M	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	426.0K	-40.85M	0.000
YoY Change	-14.8%		-100.0%
NET CHANGE
Cash From Operating Activities	-725.0K	-316.3K	-142.0K
Cash From Investing Activities	0.000	40.85M	0.000
Cash From Financing Activities	426.0K	-40.85M	0.000
Net Change In Cash	-299.0K	-316.3K	-142.0K
YoY Change	-176.22%	122.78%	-277.48%
FREE CASH FLOW
Cash From Operating Activities	-$725.0K	-$316.3K	-$142.0K
Capital Expenditures	$0.00	$2.067M
Free Cash Flow	-$725.0K	-$2.383M
YoY Change	573.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2021Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable		usd
CY2022Q3	vcka	Transaction Costs Allocated To Warrant Liabilities TransactionCostsAllocatedToWarrantLiabilities		usd
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13176395	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15862288	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39852
	dei	Entity Registrant Name EntityRegistrantName	VICKERS VANTAGE CORP. I
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1 Harbourfront Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#16-06
	dei	Entity Address City Or Town EntityAddressCityOrTown	Keppel Bay Tower
	dei	Entity Address Country EntityAddressCountry	SG
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	098632
	dei	City Area Code CityAreaCode	(646)
	dei	Local Phone Number LocalPhoneNumber	974-8301
	dei	Security12b Title Security12bTitle	Ordinary Shares, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	VCKA
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13176395	shares
CY2022Q3	us-gaap	Cash Cash	34961	usd
CY2021Q4	us-gaap	Cash Cash	507921	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	130788	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4536	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	165749	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	512457	usd
CY2022Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	101293086	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	139410739	usd
CY2022Q3	us-gaap	Assets Assets	101458835	usd
CY2021Q4	us-gaap	Assets Assets	139923196	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	809292	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	208704	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	809292	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	208704	usd
CY2022Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2035000	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	483099	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6892	usd
CY2022Q3	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	2971667	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	1162800	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	3351600	usd
CY2022Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	5190000	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	5190000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	12168759	usd
CY2021Q4	us-gaap	Liabilities Liabilities	9240295	usd
CY2022Q3	vcka	Ordinary Shares Subject To Possible Redemption OrdinarySharesSubjectToPossibleRedemption	9726395	shares
CY2021Q4	vcka	Ordinary Shares Subject To Possible Redemption OrdinarySharesSubjectToPossibleRedemption	13800000	shares
CY2022Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.41
CY2021Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	101293086	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	139380000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3450000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3450000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3450000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3450000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	345	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	345	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12003355	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8697444	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-12003010	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8697099	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	101458835	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	139923196	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	657746	usd
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	283346	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2412297	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	620642	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-657746	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-283346	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2412297	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-620642	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-68400	usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1162800	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2188800	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2872800	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-2599200	usd
	vcka	Transaction Costs Allocated To Warrant Liabilities TransactionCostsAllocatedToWarrantLiabilities	30212	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	6892	usd
	us-gaap	Distributions On Mandatorily Redeemable Securities DistributionsOnMandatorilyRedeemableSecurities	192049	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1155	usd
	us-gaap	Interest Expense InterestExpense	16901	usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	459114	usd
CY2021Q3	us-gaap	Interest Income Other InterestIncomeOther	1794	usd
	us-gaap	Interest Income Other InterestIncomeOther	664973	usd
	us-gaap	Interest Income Other InterestIncomeOther	28006	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	526359	usd
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1161006	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3035813	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	271394	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-131387	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1444352	usd
	us-gaap	Net Income Loss NetIncomeLoss	623516	usd
	us-gaap	Net Income Loss NetIncomeLoss	-349248	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13176395	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17250000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15862288	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16675824	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8697099	usd
CY2022Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	1035000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-806222	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-10538321	usd
CY2022Q2	us-gaap	Net Shares Reclassified To Mandatorily Redeemable Capital Stock Value NetSharesReclassifiedToMandatorilyRedeemableCapitalStockValue	-192049	usd
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	1595486	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1561125	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-10764731	usd
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	1106892	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-131387	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-12003010	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	18724	usd
CY2021Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	9499261	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	1328853	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-8151684	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-233749	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-8385433	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1444352	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-9829785	usd
	us-gaap	Net Income Loss NetIncomeLoss	623516	usd
	us-gaap	Net Income Loss NetIncomeLoss	-349248	usd
	us-gaap	Interest And Dividend Income Securities Held To Maturity InterestAndDividendIncomeSecuritiesHeldToMaturity	664973	usd
	us-gaap	Interest And Dividend Income Securities Held To Maturity InterestAndDividendIncomeSecuritiesHeldToMaturity	28006	usd
	us-gaap	Distributions On Mandatorily Redeemable Securities DistributionsOnMandatorilyRedeemableSecurities	192049	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2188800	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2872800	usd
	vcka	Loss On Initial Issuance Of Warrant Liability LossOnInitialIssuanceOfWarrantLiability	2599200	usd
	vcka	Change In Fair Value Of Conversion Option Liability ChangeInFairValueOfConversionOptionLiability	-6892	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	16901	usd
	vcka	Transactions Costs Allocated To Private Warrants TransactionsCostsAllocatedToPrivateWarrants	30212	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	126252	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	116536	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	600588	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	43569	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1937961	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-693609	usd
	vcka	Investment Of Cash In Trust Accounts InvestmentOfCashInTrustAccounts	3041666	usd
	vcka	Investment Of Cash In Trust Accounts InvestmentOfCashInTrustAccounts	139380000	usd
	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund	41824292	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	38782626	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-139380000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	135600000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5130000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	25000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	55000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	1535000	usd
	vcka	Proceeds From Simple Promissory Note Related Party ProceedsFromSimplePromissoryNoteRelatedParty	2971667	usd
	vcka	Repayment Of Promissory Note Related Party RepaymentOfPromissoryNoteRelatedParty	125000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	416260	usd
	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	41824292	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-37317625	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	140158740	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-472960	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	85131	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	507921	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30511	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34961	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115642	usd
	vcka	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	5190000	usd
CY2021Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2021Q1	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	138000000	usd
CY2022Q3	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	8149473	usd
	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	2400000	usd
	vcka	Deferred Underwriting Fees DeferredUnderwritingFees	5190000	usd
CY2022Q3	us-gaap	Other Ownership Interests Offering Costs OtherOwnershipInterestsOfferingCosts	559473	usd
CY2022Q3	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	3365554	usd
CY2022Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	101293086	usd
	vcka	Sale Of Stock Description Of Transactions SaleOfStockDescriptionOfTransactions	The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.
	vcka	Price Per Public Share PricePerPublicShare	10.38
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5000001	usd
	vcka	Percentage Of Public Shares PercentageOfPublicShares	0.20	pure
CY2022Q3	vcka	Business Combination Redeem Percentage BusinessCombinationRedeemPercentage	1	pure
	us-gaap	Other Expenses OtherExpenses	50000	usd
	vcka	Deposit Into The Trust Account Per Share DepositIntoTheTrustAccountPerShare	10.38
	vcka	Lesser Public Per Share LesserPublicPerShare	10.1
	us-gaap	Business Combination Acquired Receivables Description BusinessCombinationAcquiredReceivablesDescription	In connection with its solicitation of proxies in connection with the Extension Proposal, the Company was required to permit its public shareholders to redeem their ordinary shares. Of the 13,800,000 ordinary shares outstanding with redemption rights, the holders of 4,073,605 ordinary shares elected to redeem their shares at a per share redemption price of $10.25. As a result, approximately $41.8 million was removed from the Trust Account to pay such holders and approximately $99.8 million remained in the Trust Account. Following the redemptions, the Company has 9,726,395 ordinary shares with redemption rights outstanding and the Company will deposit $323,888 (or approximately $0.0333 per ordinary share that remains outstanding) for each calendar month, or portion thereof, that is needed by the Company to complete an initial business combination from July 11, 2022.
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	1295556	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	34961	usd
CY2022Q3	vcka	Working Capital WorkingCapital	643543	usd
	us-gaap	Interest Income Deposit With Financial Institution Increase Decrease InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease	696000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information because available and accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p>
CY2022Q3	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	8119261	usd
CY2021	vcka	Gross Proceeds GrossProceeds	138000000	usd
CY2021	vcka	Ordinary Shares Issuance Cost OrdinarySharesIssuanceCost	8119261	usd
CY2021Q4	vcka	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	9499261	usd
CY2021	vcka	Shares Subject To Possible Redemption SharesSubjectToPossibleRedemption	139380000	usd
	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-41824292	usd
CY2022Q3	vcka	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	3737378	usd
	vcka	Shares Subject To Possible Redemption SharesSubjectToPossibleRedemption	101293086	usd
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	13740000	shares
CY2022Q3	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-131387	usd
CY2021Q3	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-1444352	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	623516	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-349248	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	13176395	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	17250000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15862288	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	16675824	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p>
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	vcka	Purchase Price Per Share PurchasePricePerShare	10
CY2022Q1	vcka	Deferred Underwriting Commission Payable DeferredUnderwritingCommissionPayable	0.50	pure
	us-gaap	Business Combination Control Obtained Description BusinessCombinationControlObtainedDescription	The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $0.75 per warrant.
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	500000	usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	500000	usd
CY2021Q4	vcka	Warrants Exercise Price WarrantsExercisePrice	0.75
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1035000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	500000	usd
CY2022Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	1155	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	16901	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	16901	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1500000	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	500000	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	2971667	usd
CY2021	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	0	usd
	us-gaap	Related Party Transaction Description Of Transaction RelatedPartyTransactionDescriptionOfTransaction	In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees must deposit into the Trust Account $1,035,000 ($0.075 per Public Share in either case), on or prior to the date of the applicable deadline, for each three-month extension.
CY2022Q2	vcka	Deposited In Trust Account DepositedInTrustAccount	1035000	usd
CY2022Q2	vcka	Warrants Exercise Price WarrantsExercisePrice	0.75
CY2022Q3	vcka	Deposited In Trust Account DepositedInTrustAccount	1035000	usd
CY2022Q3	vcka	Deposited In Trust Account DepositedInTrustAccount	323889	usd
CY2022Q3	vcka	Deposited In Trust Account DepositedInTrustAccount	323889	usd
	us-gaap	Other Commitments Description OtherCommitmentsDescription	The underwriters are entitled to a deferred fee of (i) 3.5% of the gross proceeds of the initial 12,000,000 Units sold in the Initial Public Offering, or $4,200,000, and (ii) 5.5% of the gross proceeds from the Units sold pursuant to the over-allotment option, or $990,000.
	vcka	Merger Consideration Description MergerConsiderationDescription	The total consideration to be paid to the holders of Scilex common stock at Closing (the “Merger Consideration”) by VCKA twill be an amount equal to the quotient of (a) the sum of (i) $1,500,000,000 minus (ii) the aggregate amount of Scilex long term debt excluding intercompany debt owed to Sorrento existing as of immediately prior to the date of the closing of the transaction (the “Closing Date”); divided by (b) $10.00, and will be payable in shares of common stock, par value $0.0001 per shares, of VCKA upon its domestication in Delaware (“VCKA Common Stock”).
	vcka	Common Stock Aggregate Value CommonStockAggregateValue	1500000000	usd
CY2022Q3	vcka	Net Tangible Assets NetTangibleAssets	5000001	usd
CY2022Q1	vcka	Aggregate Percentage AggregatePercentage	0.75	pure
CY2022Q1	vcka	Warrants Percentage WarrantsPercentage	0.40	pure
CY2022Q1	vcka	Balance In The Trust Account BalanceInTheTrustAccount	25000000	usd
CY2022Q1	vcka	Deferred Underwriting Commission DeferredUnderwritingCommission	0.50	pure
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3450000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3450000	shares
CY2022Q3	vcka	Ordinary Shares Subject To Possible Redemption OrdinarySharesSubjectToPossibleRedemption	9726395	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3450000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3450000	shares
CY2021Q4	vcka	Ordinary Shares Subject To Possible Redemption OrdinarySharesSubjectToPossibleRedemption	13800000	shares
	vcka	Public Warrants Redemption Description PublicWarrantsRedemptionDescription	The Company may redeem the Public Warrants: ●in whole and not in part; ●at a price of $0.01 per warrant; ●at any time while the warrants become exercisable; ●upon not less than 30 days’ prior written notice of redemption to each warrant holder; ●if, and only if, the reported last sale price of the Company’s ordinary shares equals or exceeds $18.00 per share (subject to adjustment) for any 20 trading days within a 30-trading day period commencing after the warrants become exercisable and ending on the third trading business day prior to the notice of redemption to the warrant holders; and ●if, and only if, there is a current registration statement in effect with respect to the issuance of the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.
	vcka	Capital Raising Description CapitalRaisingDescription	In addition, if (x) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsors or its affiliates, without taking into account any Founder Shares held by the Sponsors or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
CY2022Q3	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	101293086	usd
CY2021Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	139410739	usd
	us-gaap	Fair Value Measurements Highest And Best Use Description FairValueMeasurementsHighestAndBestUseDescription	The Company established the initial fair value for the private warrants on January 11, 2021, the date of the Company’s Initial Public Offering, using a Monte Carlo simulation and subsequently implemented the Black-Scholes Option Pricing Model that was modified to capture the redemption features of the public warrants. The underlying assumptions in the Black-Scholes option pricing model include the underlying share price, risk-free interest rate, estimated volatility and the expected term. The primary unobservable inputs utilized in determining the fair value of the private warrants are the expected volatility of the Company’s ordinary shares and the Company’s ordinary share price. The expected volatility of the ordinary shares was determined based on implied volatilities of public warrants issued by selected guideline companies and was estimated to be 10% before the expected business combination and 20% after the expected business combination. The ordinary share price was determined based on an iterative procedure that matched the estimated value of the ordinary shares and fractional warrant price to equate to the observed price of the outstanding units. The risk-free interest rate is based on the U.S. Treasury yield curve in effect on the date of valuation equal to the remaining expected life of the private warrants. The dividend yield percentage is zero because the Company does not currently pay dividends, nor does it intend to do so during the expected term of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. Inputs are re-evaluated each quarterly reporting period to estimate the fair market value of the private placement warrants as of the reporting period.
CY2022Q3	us-gaap	Share Price SharePrice	10.33
CY2021Q4	us-gaap	Share Price SharePrice	10.04
CY2022Q3	vcka	Fair Value Measurement Strike Price FairValueMeasurementStrikePrice	11.5
CY2021Q4	vcka	Fair Value Measurement Strike Price FairValueMeasurementStrikePrice	11.5
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y3M10D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.083	pure
CY2022Q3	vcka	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate1 ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1	0.0403	pure
CY2021Q4	vcka	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate1 ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1	0.0128	pure
CY2022Q3	vcka	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate1 ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate1	0	pure
CY2021Q4	vcka	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate1 ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate1	0	pure
CY2022Q3	vcka	Fair Value Of Warrantsin Dollars FairValueOfWarrantsinDollars	0.17
CY2021Q4	vcka	Fair Value Of Warrantsin Dollars FairValueOfWarrantsinDollars	0.49
	vcka	Underlying Warrant Value UnderlyingWarrantValue	0
CY2021	vcka	Underlying Warrant Value UnderlyingWarrantValue	0.0103
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.75
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.75
	vcka	Holding Period HoldingPeriod	0.5
CY2021	vcka	Holding Period HoldingPeriod	0.28
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0403	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0128	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.053	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.083	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2022Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent		usd
CY2021Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
CY2021Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
CY2021Q3	vcka	Transaction Costs Allocated To Warrant Liabilities TransactionCostsAllocatedToWarrantLiabilities		usd
	vcka	Transaction Costs Allocated To Warrant Liabilities TransactionCostsAllocatedToWarrantLiabilities		usd
CY2021Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2021Q3	us-gaap	Distributions On Mandatorily Redeemable Securities DistributionsOnMandatorilyRedeemableSecurities		usd
	us-gaap	Distributions On Mandatorily Redeemable Securities DistributionsOnMandatorilyRedeemableSecurities		usd
CY2021Q3	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16675824	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17250000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	vcka	Loss On Initial Issuance Of Warrant Liability LossOnInitialIssuanceOfWarrantLiability		usd
	vcka	Change In Fair Value Of Conversion Option Liability ChangeInFairValueOfConversionOptionLiability		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	vcka	Transactions Costs Allocated To Private Warrants TransactionsCostsAllocatedToPrivateWarrants		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
	vcka	Proceeds From Simple Promissory Note Related Party ProceedsFromSimplePromissoryNoteRelatedParty		usd
	vcka	Repayment Of Promissory Note Related Party RepaymentOfPromissoryNoteRelatedParty		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	vcka	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13176395	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15862288	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16675824	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17250000	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001820190

Files In Submission

Name	View Source	Status
0001213900-22-069366-index-headers.html	Edgar Link	pending
0001213900-22-069366-index.html	Edgar Link	pending
0001213900-22-069366.txt	Edgar Link	pending
0001213900-22-069366-xbrl.zip	Edgar Link	pending
f10q0922ex31-1_vickers1.htm	Edgar Link	pending
f10q0922ex31-2_vickers1.htm	Edgar Link	pending
f10q0922ex32-1_vickers1.htm	Edgar Link	pending
f10q0922ex32-2_vickers1.htm	Edgar Link	pending
f10q0922_vickersvantage1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
f10q0922_vickersvantage1_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vcka-20220930.xsd	Edgar Link	pending
vcka-20220930_cal.xml	Edgar Link	unprocessable
vcka-20220930_def.xml	Edgar Link	unprocessable
vcka-20220930_lab.xml	Edgar Link	unprocessable
vcka-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCLX
Scilex Holding Co Stock $sclx

2022 Q4 Form 10-Q Financial Statement

#000121390022069366 Filed on November 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCLX Scilex Holding Co Stock $sclx

2022 Q4 Form 10-Q Financial Statement

#000121390022069366 Filed on November 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCLX
Scilex Holding Co Stock $sclx